BlackRock Health Sciences Term Trust $BMEZ Stake Increased by Rivernorth Capital Management LLC

Rivernorth Capital Management LLC increased its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 24.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 809,196 shares of the company’s stock after buying an additional 160,629 shares during the quarter. Rivernorth Capital Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $11,620,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Bank of America Corp DE boosted its position in BlackRock Health Sciences Term Trust by 4.1% during the 3rd quarter. Bank of America Corp DE now owns 1,535,091 shares of the company’s stock worth $22,136,000 after acquiring an additional 61,105 shares during the period. Invesco Ltd. lifted its position in shares of BlackRock Health Sciences Term Trust by 42.7% in the third quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock worth $13,398,000 after purchasing an additional 278,024 shares in the last quarter. Saba Capital Management L.P. acquired a new stake in shares of BlackRock Health Sciences Term Trust during the first quarter worth approximately $10,907,000. Lazard Asset Management LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 64.2% during the first quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock worth $8,926,000 after purchasing an additional 243,054 shares during the period. Finally, Wolverine Asset Management LLC grew its position in BlackRock Health Sciences Term Trust by 78.8% during the fourth quarter. Wolverine Asset Management LLC now owns 401,511 shares of the company’s stock valued at $6,043,000 after purchasing an additional 176,993 shares in the last quarter.

BlackRock Health Sciences Term Trust Price Performance

Shares of NYSE:BMEZ opened at $15.46 on Wednesday. The firm has a fifty day moving average of $14.88 and a two-hundred day moving average of $14.72. BlackRock Health Sciences Term Trust has a 12-month low of $13.67 and a 12-month high of $15.80.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be given a $0.11 dividend. This represents a c) annualized dividend and a yield of 8.5%. The ex-dividend date of this dividend is Tuesday, September 15th.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.